17 assets in Essential Hypertension

Therapeutic assets addressing Essential Hypertension, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Hydrochlorothiazide Essential Hypertension	Yuhan Corporation	P4	BBB (77)
Amlodipine Essential Hypertension	Yuhan Corporation	P4	BBB (76)
Labetalol Essential Hypertension	ProMedica Health System	P3	BB (69)
Phentermine Essential Hypertension	VIVUS LLC	P4	BB (69)
Valsartan Essential Hypertension	ARKAY Therapeutics	P4	BB (69)
vi-0521 Essential Hypertension	VIVUS LLC	P4	BB (69)
Hydralazine Essential Hypertension	ProMedica Health System	P3	BB (68)
Chlorthalidone Essential Hypertension	Yuhan Corporation	P4	BB (65)
Sacubitrilat Essential Hypertension	Ohio State University	P4	BB (65)
Clevidipine Essential Hypertension	ProMedica Health System	P3	BB (64)
Losartan Essential Hypertension	Chong Kun Dang Pharmaceutical	P4	BB (64)
Telmisartan Essential Hypertension	Yuhan Corporation	P4	B (63)
Irbesartan Essential Hypertension	Hippocration General Hospital	P2	CCC (53)
Metformin Essential Hypertension	ARKAY Therapeutics	P1/2	CCC (48)
Emraclidine Essential Hypertension	Cerevel Therapeutics, LLC	P1	CC (47)
Clonidine Essential Hypertension	University of Kansas Medical Center	P1	CC (43)
Eplerenone Essential Hypertension	Hippocration General Hospital	N/A	D (30)